Ahlberg, K., Ekman, T., & Gaston-Johansson, F. (2005). Fatigue, psychological distress, coping resources, and functional status during radiotherapy for uterine cancer. Oncology Nursing Forum, 32, 633-640.
Andersen, B.L. (1987). Sexual functioning complications in women with gynecologic cancer. Outcomes and directions for prevention. Cancer, 60(8, Suppl.), 2123-2128.
Andersen, B.L. (1993). Predicting sexual and psychologic morbidity and improving the quality of life for women with gynecologic cancer. Cancer, 71(4, Suppl.), 1678-1690.
Andersen, B.L. (1995). Quality of life for women with gynecologic cancer. Current Opinion in Obstetrics and Gynecology, 7, 69-76.
Andersen, B.L., & Jochimsen, P.R. (1985). Sexual functioning among breast cancer, gynecologic cancer, and healthy women. Journal of Consulting and Clinical Psychology, 53, 25-32.
Anderson, B. (1994). Quality of life in progressive ovarian cancer. Gynecologic Oncology, 55(3, Pt. 2), S151-S155.
Anderson, B., & Lutgendorf, S. (1997). Quality of life in gynecologic cancer survivors. CA: A Cancer Journal for Clinicians, 47, 218-225.
Armstrong, D.K., Bundy, B., Wenzel, L., Huang, H.Q., Baergen, R., Lele, S., et al. (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. New England Journal of Medicine, 354, 34-43.
Armstrong, T., Almadrones, L., & Gilbert, M.R. (2005). Chemotherapy-induced peripheral neuropathy. Oncology Nursing Forum, 32, 305-311.
Auchincloss, S.S. (1995). After treatment. Psychosocial issues in gynecologic cancer survivorship. Cancer, 76(10, Suppl.), 2117-2124.
Bachmann, G.A. (1990). Psychosexual aspects of hysterectomy. Women's Health Issues, 1, 41-49.
Berger, A.M., Berry, D.L., Christopher, K.A., Greene, A.L., Maliski, S., Swenson, K.K., et al. (2005). Oncology Nursing Society year 2004 research priorities survey. Oncology Nursing Forum, 32, 281-290.
Bodurka-Bevers, D., Basen-Engquist, K., Carmack, C.L., Fitzgerald, M.A., Wolf, J.K., de Moor, C., et al. (2000). Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecologic Oncology, 78(3, Pt. 1), 302-308.
Bookman, M.A. (1999). Extending the platinum-free interval in recurrent ovarian cancer: The role of topotecan in second-line chemotherapy. Oncologist, 4, 87-94.
Breaden, K. (1997). Cancer and beyond: The question of survivorship. Journal of Advanced Nursing, 26, 978-984.
Brennan, M.J. (1992). Lymphedema following the surgical treatment of breast cancer: A review of pathophysiology and treatment. Journal of Pain and Symptom Management, 7, 110-116.
Cain, E.N., Kohorn, E.I., Quinlan, D.M., Schwartz, P.E., Latimer, K., & Rogers, L. (1983). Psychosocial reactions to the diagnosis of gynecologic cancer. Obstetrics and Gynecology, 62, 635-641.
Carter, B.J. (1997). Women's experiences of lymphedema. Oncology Nursing Forum, 24, 875-882.
Chavez, L.R., Hubbell, F.A., Mishra, S.I., & Valdez, R.B. (1997). The influence of fatalism on self-reported use of Papanicolaou smears. American Journal of Preventive Medicine, 13, 418-424.
Cochrane, J. (2003). The experience of uncertainty for individuals with HIV/AIDS and the palliative care paradigm. International Journal of Palliative Nursing, 9, 382-388.
Cordova, M.J., Andrykowski, M.A., Kenady, D.E., McGrath, P.C., Sloan, D.A., & Redd, W. H. (1995). Frequency and correlates of posttraumatic-stress-disorder-like symptoms after treatment for breast cancer. Journal of Consulting and Clinical Psychology, 63, 981-986.
Davis, C.S., Zinkand, J.E., & Fitch, M.I. (2000). Cancer treatment-induced menopause: Meaning for breast and gynecological cancer survivors. Canadian Oncology Nursing Journal, 10, 14-21.
Donovan, H.S., & Ward, S. (2005). Representations of fatigue in women receiving chemotherapy for gynecologic cancers. Oncology Nursing Forum, 32, 113-116.
Dow, K.H. (1995). A review of late effects of cancer in women. Seminars in Oncology Nursing, 11, 128-136.
Ekman, I., Bergbom, I., Ekman, T., Berthold, H., & Mahsneh, S.M. (2004). Maintaining normality and support are central issues when receiving chemotherapy for ovarian cancer. Cancer Nursing, 27, 177-182.
Ersek, M., Ferrell, B., Dow, K., & Melancon, C. (1997). Quality of life in women with ovarian cancer. Western Journal of Nursing Research, 19, 334-350.
Felder, B.E. (2004). Hope and coping in patients with cancer diagnoses. Cancer Nursing, 27, 320-324.
Ferrell, B.R., Grant, M., Funk, B., Garcia, N., Otis-Green, S., & Schaffner, M.L. (1996). Quality of life in breast cancer. Cancer Practice, 4, 331-340.
Ferrell, B.R., Smith, S.L., Juarez, G., & Melancon, C. (2003). Meaning of illness and spirituality in ovarian cancer survivors. Oncology Nursing Forum, 30, 249-257.
Feuer, D.J., Broadley, K.E., Shepherd, J.H., & Barton, D.P. (2000). Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database of Systematic, Reviews, 4, CD002764.
Fish, L.S., & Lewis, B.E. (1999). Quality of life issues in the management of ovarian cancer. Seminars in Oncology, 26(1, Suppl. 1), 32-39.
Fitch, M., Gray, R.E., & Franssen, E. (2000). Perspectives on living with ovarian cancer: Young women's views. Canadian Oncology Nursing Journal, 10(3), 101-108.
Fitch, M.I., Gray, R.E., & Franssen, E. (2001). Perspectives on living with ovarian cancer: Older women's views. Oncology Nursing Forum, 28, 1433-1442.
Fredette, S.L. (1995). Breast cancer survivors: Concerns and coping. Cancer Nursing, 18(1), 35-46.
Gil, K.M., Mishel, M., Belyea, M., Germino, B., Porter, L., LaNey, I.C., et al. (2004). Triggers of uncertainty about recurrence and long-term treatment side effects in older African American and Caucasian breast cancer survivors. Oncology Nursing Forum, 31, 633-639.
Guidozzi, F. (1993). Living with ovarian cancer. Gynecologic Oncology, 50, 202-207.
Halstead, M.T., & Hull, M. (2001). Struggling with paradoxes: The process of spiritual development in women with cancer. Oncology Nursing Forum, 28, 1534-1544.
Harries, M., & Gore, M. (2002). Part I: Chemotherapy for epithelial ovarian cancer—Treatment at first diagnosis. Lancet Oncology, 3, 529-536.
Howell, D., Fitch, M.I., & Deane, K.A. (2003a). Impact of ovarian cancer perceived by women. Cancer Nursing, 26, 1-9.
Howell, D., Fitch, M.I., & Deane, K.A. (2003b). Women's experiences with recurrent ovarian cancer. Cancer Nursing, 26, 10-17.
Jansen, C.E., Miaskowski, C., Dodd, M., & Dowling, G. (2005). Chemotherapy-induced cognitive impairment in women with breast cancer: A critique of the literature. Oncology Nursing Forum, 32, 329-342.
Jefferies, H. (2002). Ovarian cancer patients: Are their informational and emotional needs being met? Journal of Clinical Nursing, 11, 41-47.
Kornblith, A.B., Thaler, H.T., Wong, G., Vlamis, V., Lepore, J.M., Loseth, D.B., et al. (1995). Quality of life of women with ovarian cancer. Gynecologic Oncology, 59, 231-242.
Lakusta, C.M., Atkinson, M.J., Robinson, J.W., Nation, J., Taenzer, P.A., & Campo, M.G. (2001). Quality of life in ovarian cancer patients receiving chemotherapy. Gynecologic Oncology, 81, 490-495.
Lammers, S.E., Schaefer, K.M., Ladd, E.C., & Echenberg, R. (2000). Caring for women living with ovarian cancer: Recommendations for advanced practice nurses. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 29, 567-573.
Mahon, S.M., & Casperson, D.M. (1997). Exploring the psychosocial meaning of recurrent cancer: A descriptive study. Cancer Nursing, 20, 178-186.
Markman, M. (2001). Advances in the management of recurrent or resistant ovarian cancer. In M. Markman (Ed.), Hope on the horizon for ovarian cancer management (pp. 1-6). Philadelphia: Meniscus.
Martin, V.R. (2002). Ovarian cancer. Seminars in Oncology Nursing, 18, 174-183.
McCartney, C.F., & Larson, D.B. (1987). Quality of life in patients with gynecologic cancer. Cancer, 60(8, Suppl.), 2129-2136.
McCorkle, R., Pasacreta, J., & Tang, S.T. (2003). The silent killer: Psychological issues in ovarian cancer. Holistic Nursing Practice, 17, 300-308.
McKenzie, H., & Crouch, M. (2004). Discordant feelings in the lifeworld of cancer survivors. Health, 8, 139-157.
Miaskowski, C. (1996). Special needs related to the pain and discomfort of patients with gynecologic cancer. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 25, 181-188.
Mishel, M.H. (1990). Reconceptualization of the uncertainty in illness theory. Image—The Journal of Nursing Scholarship, 22, 256-262.
Mishel, M.H., & Sorenson, D.S. (1991). Uncertainty in gynecological cancer: A test of the mediating functions of mastery and coping. Nursing Research, 40, 167-171.
Montazeri, A., McEwen, J., & Gillis, C.R. (1996). Quality of life in patients with ovarian cancer: Current state of research. Supportive Care in Cancer, 4, 169-179.
Moore-Higgs, G.J., Almadrones, L.A., Colvin-Huff, B., Gossfeld, L.M., & Eriksson, J.H. (2000). Women and cancer: A gynecologic oncology nursing perspective (2nd ed.). Sudbury, MA: Jones and Bartlett.
Nelson, J.P. (1996). Struggling to gain meaning: Living with the uncertainty of breast cancer. Advances in Nursing Science, 18(3), 59-76.
Ozols, R.F. (1995). Outcome issues in ovarian cancer. Oncology, 9(11, Suppl.), 135-139.
Payne, J.K. (2002). The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy. Oncology Nursing Forum, 29, 1334-1340.
Penson, R.T., Dignan, F., Seiden, M.V., Lee, H., Gallagher, C.J., Matulonis, U.A., et al. (2004). Attitudes to chemotherapy in patients with ovarian cancer. Gynecologic Oncology, 94, 427-435.
Pilkington, F.B., & Mitchell, G.J. (2004). Quality of life for women living with a gynecologic cancer. Nursing Science Quarterly, 17, 147-155.
Portenoy, R.K., Thaler, H.T., Kornblith, A.B., Lepore, J.M., Friedlander-Klar, H., Coyle, N., et al. (1994). Symptom prevalence, characteristics and distress in a cancer population. Quality of Life Research, 3, 183-189.
Powe, B.D., & Finnie, R. (2003). Cancer fatalism: The state of the science. Cancer Nursing, 26, 454-465.
Roberts, C.S., Rossetti, K., Cone, D., & Cavanagh, D. (1992). Psychosocial impact of gynecologic cancer: A descriptive study. Journal of Psychosocial Oncology, 10(1), 99-109.
Ryan, M., Stainton, M.C., Jaconelli, C., Watts, S., MacKenzie, P., & Mansberg, T. (2003). The experience of lower limb lymphedema for women after treatment for gynecologic cancer. Oncology Nursing Forum, 30, 417-423.
Schaefer, K.M., Ladd, E.C., Lammers, S.E., & Echenberg, R.J. (1999). In your skin you are different: Women living with ovarian cancer during childbearing years. Qualitative Health Research, 9, 227-242.
Smith, E.M., Redman, R., Burns, T.L., & Sagert, K.M. (1985). Perceptions of social support among patients with recently diagnosed breast, endometrial, and ovarian cancer: An exploratory study. Journal of Psychosocial Oncology, 3(3), 65-81.
Sonoda, Y. (2004). Management of early ovarian cancer. Oncology, 18, 343-356.
Steginga, S.K., & Dunn, J. (1997). Women's experiences following treatment for gynecologic cancer. Oncology Nursing Forum, 24, 1403-1408.
Swenson, M.M., MacLeod, J.S., Williams, S.D., Miller, A.M., & Champion, V.L. (2003). Quality of living among ovarian germ cell cancer survivors: A narrative analysis. Oncology Nursing Forum, 30, E56-E62. Retrieved March 21, 2006, from http://www.ons.org/publications/journals/ONF/Volume30/Issue3/pdf/380.pdf
Wefel, J.S., Lenzi, R., Theriault, R.L., Davis, R.N., & Meyers, C.A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer, 100, 2292-2299.
Wenzel, L.B., Donnelly, J.P., Fowler, J.M., Habbal, R., Taylor, T.H., Aziz, N., et al. (2002). Resilience, reflection, and residual stress in ovarian cancer survivorship: A gynecologic oncology group study. Psycho-Oncology, 11, 142-153.
Wilmoth, M.C., & Spinelli, A. (2000). Sexual implications of gynecologic cancer treatments. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 29, 413-421.
Zabora, J., BrintzenhofeSzoc, K., Curbow, B., Hooker, C., & Piantadosi, S. (2001). The prevalence of psychological distress by cancer site. Psycho-Oncology, 10, 19-28.
Zacharias, D.R., Gilg, C.A., & Foxall, M.J. (1994). Quality of life and coping in patients with gynecologic cancer and their spouses. Oncology Nursing Forum, 21, 1699-1706.